Trial Profile
Effect of vonoprazan, a potassium competitive acid blocker, in post endoscopic submucosal dissection ulcer healing
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Sep 2022
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 07 Sep 2022 Status changed from recruiting to discontinued.
- 20 Jun 2016 New trial record